CELLTRION Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Korea, South
- Registered address
- 23, Academy-ro, Yeonsu-gu, Incheon, 22014, Korea, South (KOR)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3005241015 · DUNS 688836030
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIBioresearch Monitoring2024-05-03
- VAIDrug Quality Assurance2024-02-27
- VAIDrug Quality Assurance2022-06-03
- VAIDrug Quality Assurance2019-10-22
- VAIDrug Quality Assurance2018-07-17
- OAIDrug Quality Assurance2017-06-02
- NAIBioresearch Monitoring2015-04-09
Drugs this plant is listed as making
0 distinct drugs across 0 products name this site in their FDA label.
No drug labels currently list this site.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.